Splenectomy Promotes Indirect Elimination of Intraocular Tumors by CD8+ T Cells That Is Associated with IFNγ- and Fas/FasL-Dependent Activation of Intratumoral Macrophages
- 1 December 2014
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 2 (12), 1175-1185
- https://doi.org/10.1158/2326-6066.cir-14-0093-t
Abstract
Ocular immune privilege (IP) limits the immune surveillance of intraocular tumors as certain immunogenic tumor cell lines (P815, E.G7-OVA) that are rejected when transplanted in the skin grow progressively when placed in the anterior chamber of the eye. As splenectomy (SPLNX) is known to terminate ocular IP, we characterized the immune mechanisms responsible for rejection of intraocular tumors in SPLNX mice as a first step toward identifying how to restore tumoricidal activity within the eye. CD8+ T cells, IFNγ, and FasL, but not perforin, or TNFα were required for the elimination of intraocular E.G7-OVA tumors that culminated in destruction of the eye (ocular phthisis). IFNγ and FasL did not target tumor cells directly as the majority of SPLNX IFNγR1−/− mice and Fas-defective lpr mice failed to eliminate intraocular E.G7-OVA tumors that expressed Fas and IFNγR1. Bone marrow chimeras revealed that IFNγR1 and Fas expression on immune cells was most critical for rejection, and SPLNX increased the frequency of activated macrophages (Mϕ) within intraocular tumors in an IFNγ- and Fas/FasL-dependent manner, suggesting an immune cell target of IFNγ and Fas. As depletion of Mϕs limited CD8 T cell–mediated rejection of intraocular tumors in SPLNX mice, our data support a model in which IFNγ- and Fas/FasL-dependent activation of intratumoral Mϕs by CD8+ T cells promotes severe intraocular inflammation that indirectly eliminates intraocular tumors by inducing phthisis, and suggests that immunosuppressive mechanisms that maintain ocular IP interfere with the interaction between CD8+ T cells and Mϕs to limit the immunosurveillance of intraocular tumors. Cancer Immunol Res; 2(12); 1175–85. ©2014 AACR.Keywords
Other Versions
This publication has 40 references indexed in Scilit:
- Influence of CD8+ T regulatory cells on intraocular tumor developmentFrontiers in Immunology, 2012
- Stimulation of Fas (CD95) induces production of pro-inflammatory mediators through ERK/JNK-dependent activation of NF-κB in THP-1 cellsCellular Immunology, 2011
- A diverse range of gene products are effectors of the type I interferon antiviral responseNature, 2011
- Abrogating TNF-α Expression Prevents Bystander Destruction of Normal Tissues during iNOS-Mediated Elimination of Intraocular TumorsCancer Research, 2011
- CTL Induction of Tumoricidal Nitric Oxide Production by Intratumoral Macrophages Is Critical for Tumor EliminationPublished by The American Association of Immunologists ,2010
- Influence of Immune Privilege on Ocular Tumor DevelopmentOcular Immunology and Inflammation, 2010
- A signature-based method for indexing cell cycle phase distribution from microarray profilesBMC Genomics, 2009
- CD4+T-cell-dependent tumour rejection in an immune-privileged environment requires macrophagesImmunology, 2008
- Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-γ-dependent mannerJournal of Leukocyte Biology, 2006
- The role of tumor stroma in the interaction between tumor and immune systemCurrent Opinion in Immunology, 2005